Ward Hadaway’s Martin Hulls wins Corporate Lawyer of the Year
9th September, 2016
THE Head of Corporate at leading North law firm Ward Hadaway has been named the Corporate Lawyer of the Year.
Martin Hulls (pictured) won the award at the North East Dealmakers Awards 2016, organised by the Insider business magazine.
He fought off competition from corporate lawyers across the North East to secure the title, which was presented at an awards dinner at the Marriott Gosforth Park Hotel in Newcastle.
Judges commented on how Martin acts for a wide range of clients, from large to small, and noted his specialist expertise in private equity transactions.
They said his “stand-out deals” over the past year were the sale of nursery business Kids 1st to Busy Bees and the investment by US-based FTV Capital in technology specialist True Potential.
Speaking about his award, Martin said: “I am delighted to win this award – it is really gratifying to be recognised in this way.
“Whilst it is an individual award, it is very much a reflection of the skill, hard work and dedication of the whole of the Corporate team at Ward Hadaway and, of course, the clients we work for.
“Without their vision, determination and ambition, none of this would be possible so this award is as much for them as it is for me.”
Martin has been Head of Corporate at Ward Hadaway since 1993.
He has more than 25 years’ experience of buying, selling and floating companies with particular experience of private equity and venture capital fund-raising.
Ward Hadaway was also involved in another of the awards made at the North East Dealmaker Awards 2016.
The event, which took place before an audience of more than 300 of the North East’s top professionals, also saw special awards handed out to mark 10 years of North East Dealmaker Awards.
Winner of the JEREMIE-funded Deal of the Decade was IP Group’s investment in IBEX Innovations, a deal which Ward Hadaway advised on.
Completed in 2014, this transaction saw £1.9m funding provided by the Finance for Business North East Technology Fund, managed by IP Group, alongside an existing strategic investor.
The funds have been be used to enable IBEX to drive the commercial adoption of its X-ray detectors in both medical and industrial markets as well as for continued product development.
Please note that this briefing is designed to be informative, not advisory and represents our understanding of English law and practice as at the date indicated. We would always recommend that you should seek specific guidance on any particular legal issue.
This page may contain links that direct you to third party websites. We have no control over and are not responsible for the content, use by you or availability of those third party websites, for any products or services you buy through those sites or for the treatment of any personal information you provide to the third party.